biomedicina slovenica


pr=Cameron : 14

  1. Schedel Michaela; Frei Remo; Bieli Christian; Cameron Lisa; Adamski Jerzy; Lauener Roger; Kabesch Michael
    An IgE-associated polymorphism in STAT6 alters NF-kappaB binding, STAT6 promoter activity, and mRNA expression
    2009
  2. Cardoso F; Costa A; Norton L; Cameron D; Čufer T; Fallowfield L; Francis P; Gligorov J; Kyriakides S; Lin N
    1st International consensus guidelines for advanced breast cancer (ABC 1)
    2012
  3. Paridaens Robert J; Dirix LucY; Beex Louk V; Nooij Marianne; Cameron David A; Čufer Tanja; Piccart Martine J; Bogaerts Jan; Therasse Patrick
    Phase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women: the European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group
    2008
  4. Pajk Bojana; Čufer Tanja; Canney Peter; Ellis Paul; Cameron David; Blot Emmanuel; Vermorken Jan; Coleman Robert; Marreaud Sandrine; Bogaerts Jan
    Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: findings from EORTC 10001 randomized phase II trial
    2008
  5. Zielinski Christoph C.; Awada Ahmad; Cameron David A.; Čufer Tanja; Martin Miguel; Aapro Matti S.
    The impact of new European organisation for research and treatment of cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patients
    2008
  6. Paridaens R; Therasse P; Dirix L; Beex L; Piccart M; Cameron D; Čufer T; Roozendaal K; Nooij M; Mattiacci M-R
    First line hormonal treatment (HT) for metastatic breast cancer (MBC) with exemestane (E) or tamoxifen (T) in postmenopausal patients (pts) - A randomized phase III trial of the EORTC breast group
    2004
  7. Atalay G; Dirix L; Biganzoli L; Beex L; Nooij M; Cameron D; Lohrisch C; Čufer T; Lobelle JP; Mattiaci MR
    The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC trial 10951, 'Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'
    2004
  8. Paridaens R; Therasse P; Dirix L; Beex L; Piccart MJ; Cameron D; Čufer T; Roozendael K; Nooy M; Mattiacci MR
    First results of a randomized phase III trial comparing exemestane versus tamoxifen as first-line hormone therapy (HT) for postmenopausal women with metastatic breast cancer (MBC) - EORTC 10951 in collaboration with the exemestane working group and NCIC clinical trials group
    2004
  9. Cameron Peter J; Giudici Michael; Gareth A; Kantor William M; Klin Mikhail; Marušič Dragan; Nowitz Lewis A
    Transitive permutation groups without semiregular subgroups
    2002
  10. Paridaens R; Dirix L; Lohrisch C; Beex L; Nooij M; Cameron D; Biganzoli L; Čufer T; Duchateau L; Hamilton A; Lobelle JP; Piccart M
    Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer
    2003
  11. Dirix L; Piccart MJ; Lohrisch C; Beex L; Nooij M; Cameron D; Biganzoli L; Čufer T; Yague C; Duchateau L
    Efficacy of and tolerance to Exemestane (E) versus Tamoxifen (T) in 1st line hormone therapy (HT) of postmenopausal metastatic breast cancer (MBC) patients (pts): a European orgnisation for the research and treatment of cancer (EORTC breast group) phase II trial with Pharmacia and Upjohn
    2001
  12. Lohrisch C; Paridaens R; Dirix LY; Beex L; Nooij M; Cameron D; Biganzoli L; Čufer T; Yague C; Duchateau L
    Adverse impact on serum lipids of the irreversible aromatase inactivator Aromasin (Exemestane (E)) in 1st line treatment of metastatic breast cancer (MBC): companion study to a European organization of research and treatment of cancer (Breast group) trial with Pharmacias' Upjohn
    2001
  13. Cameron NG; Birks HJB; Jones JV; Berge F; Catalan J; Flower RJ; Garcia J; Kawecka B; Koinig KA; Šiško M; et al ;
    Surface-sediment and epilithic diatom pH calibration sets for remote European mountain lakes (AL:PE project) and their comparison with the surface waters acidification programme (SWAP) calibration set
    1999
  14. Schreiner LJ; Cameron IG; Funduk N; Miljković L; Pintar MM; Kydon DN
    Proton NMR spin grouping and exchange in dentin
    1991


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics